Bunion (Hallux Valgus) Treatment Market Research Report– By Diagnosis (Medical History, X-Rays, Radiography), By Treatment (Self-Care, Medications, Devices, Surgery), By End User (Healthcare Service Providers, Podiatrists) – Global Forecast till 2027
ID: MRFR/Pharma/3757-HCR | | Region: Global | 90 pages
Market Scenario
A bunion is an enlargement of bone or tissue around the joint at the base of the big toe. The big toe may turn toward the second toe. The tissues around the joint may be swollen and tender. People in occupations such as teaching and nursing, which involve a lot of standing and walking are susceptible to bunions. Moreover, professions such as ballet dancers are also susceptible to severe repetitive stress. Women can develop bunions and other foot problems during pregnancy as the hormonal changes loosen the ligaments and flatten the feet. Bunions are also associated with arthritis, which damages the cartilage within the joint. There is a high prevalence of bunion (hallux valgus) in the overall population with 23% of adults aged 18-65 years and 35.7% of adults over 65 years of age. Usually, the prevalence is higher in women (30%) than in males (13%) and that of elderly is approximately 35.7%.
The treatment includes the use of bunion shields or pads, which can reduce pressure on the bunion. Custom insole orthotics can be made depending on the structure of the foot and severity of the bunion. Such insoles can slow the progression of the bunion. Bracing is used as a part of post-operative rehabilitation therapy. Furthermore, anti-inflammatory medications such as acetylsalicylic acid (aspirin, ecotrin), ibuprofen, and naproxen (anaprox, naprelan, naprosyn, aleve) may ease the inflammation and pain. This inflammation can often be relieved by a local injection of cortisone.
Osteoporosis causes decrease in the bone density causing fractures even after minor trauma. Almost 8.9 million people suffer from the disease annually causing an osteoporotic fracture every 3 seconds. It majorly affects menopausal women and causes 1 out of 3 women over the age of 50 to experience an osteoporotic fracture. The most common complication is a recurrence of the bunion, reported in as many as 16% of cases. This may happen when only the bony prominence is shaved off and the underlying deformity is not corrected.
The global bunion treatment market is expected to grow at a CAGR of approximately 6.5% during the forecast period 2017-2023.
Intended Audience
- Bunion Devices Suppliers
- Bunion Drug Manufacturers
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Segmentation
The bunion treatment is segmented on the basis of diagnosis, treatment, and end-users.
On the basis of the diagnosis, the market is segmented into medical history, physical examination, X-rays, radiography, and others.
On the basis of the treatment, the market is segmented into self-care, medications, devices, medical procedures, and surgery. The self-care is segmented into wide shoes, cold compress, and bunion pads. The medication is sub-segmented into analgesic and non-steroidal anti-inflammatory drug. The device is segmented into braces. The medical procedure is divided into callus shaving and the surgery is classified into bone surgery. Furthermore, the bone surgery is classified into different types including distal chevron osteotomy, scarf or ludloff osteotomy, crescent osteotomy, and lapidus procedure.
On the basis of the end-user, the market is segmented into healthcare service providers, podiatrists, research organizations, and academic institutes.
Regional Analysis
The global bunion treatment market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is projected to hold the largest share of the global bunion treatment market due to the trending lifestyle in the U.S. Mergers and acquisitions are also expected to contribute to the market growth. For example, Stryker Corporation’s acquisition of the assets of Small Bone Innovations in 2014 added to the company’s small joint replacement products, following which the net sales of the company increased by 9.6% in the same year. All the aforementioned factors are anticipated to boost the market growth in the U.S. and ensure its dominance over the forecast period.
Europe is expected to capture the second lead in this market in the coming five years owing to substantial technological advancements. The market in the Asia Pacific is expected to witness the fastest growth rate within the forecast period due to increasing geriatric population coupled with increasing number of podiatrists. Additionally, better and improving healthcare infrastructure and increasing healthcare spending are also expected to boost the market growth in this region within the forecast period. Latin America and the Middle East and Africa are also expected to show a healthy growth in the coming five years.
Key Players
The existing players are strengthening their foothold in the industry by introducing technologically advanced products. Regulatory bodies such as the US FDA and the European CE mark, although stringent, are approving equipment that fulfills all clinical data requirement and other safety criteria. For instance, in September 2015, Extremity Medical received FDA approval for IOFiX Foot and Ankle System.
Some of key the players in the global bunion treatment market are Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Smith & Nephew plc (U.K.), Wright Medical Technology, Inc. (U.S.), Integra LifeSciences Holdings Corporation (U.S.), Tornier N.V. (Netherlands), Össur (Iceland), Acumed, LLC (U.S.), and Extremity Medical, LLC (U.S.), De Puy Synthes (U.S.), Biomet, Inc. (U.S.), BioPro, Inc. (U.S.), Orthofix Holdings Inc. (U.S.), OrthoHelix Surgical Designs, Inc. (U.S.), Mondeal Medical Systems GmbH (Germany), and others.
Research Methodology
Sources: Annual reports, Press release, White paper, and Company presentation
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Bunion (hallux valgus) Treatment Market, by Diagnosis
6.1 Introduction
6.2 Medical history
6.2.1 Market Estimates & Forecast, 2020 – 2027
6.3 Physical examination
6.3.1 Market Estimates & Forecast, 2020 – 2027
6.4 X-ray
6.4.1 Market Estimates & Forecast, 2020 – 2027
6.5 Radiography
6.5.1 Market Estimates & Forecast, 2020 – 2027
6.5 Others
Chapter 7. Global Bunion (hallux valgus) Treatment Market, by Treatment
7.1 Introduction
7.2 Self-care
7.2.1 Market Estimates & Forecast, 2020 – 2027
7.2.2 Wide shoes
7.2.2.1 Market Estimates & Forecast, 2020 – 2027
7.2.3 Cold compress
7.2.3.1 Market Estimates & Forecast, 2020 – 2027
7.2.4 Bunioun pads
7.2.4.1 Market Estimates & Forecast, 2020 – 2027
7.3 Medications
7.3.1 Market Estimates & Forecast, 2020 – 2027
7.3.2 Analgesic
7.3.2.1 Market Estimates & Forecast, 2020 – 2027
7.3.3 Non-steroidal anti-inflammatory drug
7.3.3.1 Market Estimates & Forecast, 2020 – 2027
7.4 Devices
7.4.1 Market Estimates & Forecast, 2020 – 2027
7.4.2 Braces
7.4.2.1 Market Estimates & Forecast, 2020 – 2027
7.5 Medical Procedure
7.5.1 Market Estimates & Forecast, 2020 – 2027
7.5.2 Callus shaving
7.5.2.1 Market Estimates & Forecast, 2020 – 2027
7.6 Surgery
7.6.1 Market Estimates & Forecast, 2020 – 2027
7.6.2 Bone surgery
7.6.2.1 Market Estimates & Forecast, 2020 – 2027
7.6.2.2 Distal chevron osteotomy
7.6.2.2.1 Market Estimates & Forecast, 2020 – 2027
7.6.2.3 Scarf or ludloff osteotomy
7.6.2.3.1 Market Estimates & Forecast, 2020 – 2027
7.6.2.4 Crescent osteotomy
7.6.2.4.1 Market Estimates & Forecast, 2020 – 2027
7.6.2.5 Lapidus procedure
7.6.2.5.1 Market Estimates & Forecast, 2020 – 2027
Chapter 8. Global Bunion (hallux valgus) Treatment Market, by End User
8.1 Introduction
8.2 Healthcare service providers
8.2.1 Market Estimates & Forecast, 2020 – 2027
8.3 Podiatrists
8.3.1 Market Estimates & Forecast, 2020 – 2027
8.4 Research organizations
8.4.1 Market Estimates & Forecast, 2020 – 2027
8.5 Academic institutes
8.5.1 Market Estimates & Forecast, 2020 – 2027
Chapter. 9 Global Bunion (hallux valgus) Treatment Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Rest of the Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Stryker Corporation
11.1.1 Company Overview
11.1.2 Treatment Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Arthrex, Inc.
11.2.1 Company Overview
11.2.2 Treatment Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Zimmer Biomet Holdings, Inc.
11.3.1 Company Overview
11.3.2 Treatment Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Smith & Nephew plc
11.4.1 Company Overview
11.4.2 Treatment/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Wright Medical Technology, Inc.
11.5.1 Company Overview
11.5.2 Treatment Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 Integra LifeSciences Holdings Corporation
11.6.1 Company Overview
11.6.2 Treatment Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 Tornier N.V.
11.7.1 Overview
11.7.2 Treatment Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Össur
11.8.1 Company Overview
11.8.2 Treatment/Business Segment Overview
11.8.3 Financial Overview
11.8.4 Key Development
11.8.5 SWOT Analysis
11.9 Acumed, LLC
11.9.1 Company Overview
11.9.2 Treatment Overview
11.9.3 Financial overview
11.9.4 Key Developments
11.10 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Pharmaceutical industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Bunion treatment Industry Synopsis, 2020 – 2027
Table 2 Bunion (hallux valgus) Treatment Market Estimates and Forecast, 2020 – 2027, (USD Million)
Table 3 Bunion (hallux valgus) Treatment Market by Region, 2020 – 2027, (USD Million)
Table 4 Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 5 Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 6 Bunion (hallux valgus) Treatment Market by End Users, 2020 – 2027, (USD Million)
Table 7 North America Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 8 North America Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 9 North America Bunion (hallux valgus) Treatment Market by End User, 2020 – 2027, (USD Million)
Table 10 US Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 11 US Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 12 US Bunion (hallux valgus) Treatment Market by End User, 2020 – 2027, (USD Million)
Table 13 Canada Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 14 Canada Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 15 Canada Bunion (hallux valgus) Treatment Market by End User, 2020 – 2027, (USD Million)
Table 16 South America Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 17 South America Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 18 South America Bunion (hallux valgus) Treatment Market by End User, 2020 – 2027, (USD Million)
Table 19 Europe Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 20 Europe Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 21 Europe Bunion (hallux valgus) Treatment Market by End User, 2020 – 2027, (USD Million)
Table 22 Western Europe Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 23 Western Europe Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 24 Western Europe Bunion (hallux valgus) Treatment Market by End User, 2020 – 2027, (USD Million)
Table 25 Eastern Europe Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 26 Eastern Europe Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 27 Eastern Europe Bunion (hallux valgus) Treatment Market by End User, 2020 – 2027, (USD Million)
Table 28 Asia Pacific Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 29 Asia Pacific Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 30 Asia Pacific Bunion (hallux valgus) Treatment Market by End User, 2020 – 2027, (USD Million)
Table 31 The Middle East & Africa Bunion (hallux valgus) Treatment Market by Diagnosis, 2020 – 2027, (USD Million)
Table 32 The Middle East & Africa Bunion (hallux valgus) Treatment Market by Treatment, 2020 – 2027, (USD Million)
Table 33 The Middle East & Africa Bunion (hallux valgus) Treatment Market by End User, 2020 – 2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Bunion (hallux valgus) Treatment Market
Figure 3 Segmentation Market Dynamics for Bunion (hallux valgus) Treatment Market
Figure 4 Global Bunion (hallux valgus) Treatment Market Share, by Diagnosis 2020
Figure 5 Global Bunion (hallux valgus) Treatment Market Share, by Treatment 2020
Figure 6 Global Bunion (hallux valgus) Treatment Market Share, by End Users, 2020
Figure 7 Global Bunion (hallux valgus) Treatment Market Share, by Region, 2020
Figure 8 North America Bunion (hallux valgus) Treatment Market Share, by Country, 2020
Figure 9 Europe Bunion (hallux valgus) Treatment Market Share, by Country, 2020
Figure 10 Asia Pacific Bunion (hallux valgus) Treatment Market Share, by Country, 2020
Figure 11 The Middle East & Africa Bunion (hallux valgus) Treatment Market Share, by Country, 2020
Figure 12 Global Bunion (hallux valgus) Treatment Market: Company Share Analysis, 2020 (%)
Figure 13 Stryker Corporation: Key Financials
Figure 14 Stryker Corporation: Segmental Revenue
Figure 15 Stryker Corporation: Geographical Revenue
Figure 16 Arthrex, Inc.: Key Financials
Figure 17 Arthrex, Inc.: Segmental Revenue
Figure 18 Arthrex, Inc.: Geographical Revenue
Figure 19 Zimmer Biomet Holdings, Inc..: Key Financials
Figure 20 Zimmer Biomet Holdings, Inc..: Segmental Revenue
Figure 22 Zimmer Biomet Holdings, Inc..: Geographical Revenue
Figure 23 Smith & Nephew plc: Key Financials
Figure 24 Smith & Nephew plc: Segmental Revenue
Figure 25 Smith & Nephew plc: Geographical Revenue
Figure 27 Wright Medical Technology, Inc.: Key Financials
Figure 28 Wright Medical Technology, Inc.: Segmental Revenue
Figure 29 Wright Medical Technology, Inc.: Geographical Revenue
Figure 30 Integra LifeSciences Holdings Corporation: Key Financials
Figure 32 Integra LifeSciences Holdings Corporation: Segmental Revenue
Figure 33 Integra LifeSciences Holdings Corporation: Geographical Revenue
Figure 33 Tornier N.V.: Key Financials
Figure 34 Tornier N.V.: Segmental Revenue
Figure 35 Tornier N.V.: Geographical Revenue
Figure 36 Össur: Key Financials
Figure 37 Össur: Segmental Revenue
Figure 38 Össur: Geographical Revenue
Figure 39 Acumed, LLC: Key Financials
Figure 40 Acumed, LLC: Segmental Revenue
Figure 41 Acumed, LLC: Geographical Revenue
